Letrozole - a new breast cancer drug lowers estrogen levels far more effective than the most popular current therapy, shows study.

They found post-menopausal women on letrozole were 20 per cent less likely to suffer a return of breast cancer over an eight-year period and 21 per cent less likely to die.
Source-ANI